Parkinson’s Discovery Suggests We May Already Have an FDA-Approved Treatment

Shared from sciencealert.com.

Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for Parkinson’s disease from cell-to-cell in the brain.

Promisingly, an FDA-approved cancer drug that targets another protein called Lag3 – which interacts with Aplp1 – blocks the spread in mice, suggesting a potential therapy may already exist.

more news & info

Upcoming Events